Ludwig Gutmann

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

DCTN1 mutations in Perry syndrome

Matthew J. Farrer, Mary Hulihan, Jennifer M. Kachergus et al. · Nature Genetics · 2009 · 322 citations · Full text

Life Sciences, Genetics, Molecular Genetics +5

High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA

Claire Janoir, Valérie Zeller, Marie-Dominique Kitzis et al. · Antimicrobial Agents and Chemotherapy · 1996 · 230 citations · Full text

Life Sciences, Microbiology, Molecular Genetics +17

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban et al. · The Lancet Neurology · 2019 · 223 citations · Full text

Medicine, Endocrinology, Surgery +5

Cross-Resistance to Nalidixic Acid, Trimethoprim, and Chloramphenicol Associated with Alterations in Outer Membrane Proteins of Klebsiella, Enterobacter, and Serratia

Ludwig Gutmann, R. Williamson, N. Moreau et al. · The Journal of Infectious Diseases · 1985 · 188 citations

Life Sciences, Microbiology, Molecular Biology +17